Check out our most popular compounded medications! Get Started
Codeine Phosphate 90 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat conditions such as chronic pain, cough, dyspnea, dysuria, and diarrhea. The slow release mechanism reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Codeine Phosphate 90 mg Slow Release Capsules are a specially compounded prescription medication designed to manage moderate to severe pain. The formulation utilizes Methocel E4M, a type of controlled-release polymer, which ensures a gradual release of the active ingredient, codeine phosphate, over an extended period. This slow and steady release mechanism offers sustained therapeutic effects, providing consistent pain relief throughout the day and reducing the need for frequent dosing.
Codeine phosphate is an opioid analgesic, which functions by blocking pain signals from reaching the brain.
It is crucial to take Codeine Phosphate 90 mg Slow Release Capsules as directed by your healthcare provider. Always adhere to the instructions on the label and avoid exceeding the recommended dose. Overdosing on this medication can lead to severe side effects, including respiratory depression, coma, and even death.
If you have any queries or concerns regarding Codeine Phosphate 90 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is available to provide the necessary guidance and support. Please remember, your health and safety are our top priority.
Codeine Phosphate 90 mg Slow Release Capsules are a compounded formulation designed for the treatment of mild to moderate pain, including pain associated with dysmenorrhea, postoperative pain, and cancer pain. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the active ingredient over an extended period of time. This results in sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Patients should exercise caution when using Codeine Phosphate 90 mg Slow Release Capsules, especially those with a history of drug abuse, mental illness, or suicidal thoughts. Regular monitoring for signs of addiction or abuse is recommended. It's important to note that this medication may interact with other substances, including alcohol, antihistamines, antidepressants, antifungals, barbiturates, benzodiazepines, diuretics, MAO inhibitors, muscle relaxants, opioids, sedatives, and sleeping pills. Therefore, patients should inform their healthcare provider of all medications they are currently taking before starting this treatment.
Side effects of Codeine Phosphate 90 mg Slow Release Capsules may include drowsiness, dizziness, or confusion. Patients are advised not to drive or operate heavy machinery until they understand how this medication affects them. Alcohol consumption should also be avoided while taking this medication. This medication is not recommended for use in pregnant or breastfeeding women, as it may cause harm to the fetus or infant. Patients should also inform their healthcare provider if they have any allergies or medical conditions, such as asthma, kidney or liver disease, or a history of seizures.
If you have any questions about Codeine Phosphate 90 mg Slow Release Capsules, please do not hesitate to reach out for further information.
Codeine Phosphate 90 mg Slow Release Capsules are a potent formulation designed to provide relief from moderate to severe pain. This formulation employs Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient, Codeine Phosphate, over an extended period. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
Codeine Phosphate is an opioid analgesic, which functions by inhibiting pain signals from reaching the brain. It is crucial to understand that Codeine Phosphate is not suitable for treating mild pain or pain that is expected to be short-lived. The slow release formulation of these capsules provides a consistent level of pain relief over time, enhancing the overall effectiveness of the medication.
Codeine Phosphate 90 mg Slow Release Capsules are to be taken orally, with or without food. It is essential to adhere strictly to the dosage prescribed by your healthcare provider. Avoid taking more or less than the recommended dose, and do not take it more frequently than advised. Abrupt discontinuation of the medication should also be avoided as it can lead to withdrawal symptoms.
It is important to be aware that Codeine Phosphate 90 mg Slow Release Capsules can be habit-forming. Therefore, it should only be used as prescribed by a healthcare professional. Potential side effects of this medication can include nausea, vomiting, constipation, dizziness, drowsiness, and dry mouth. If you experience any of these side effects, it is advised to contact your healthcare provider immediately.
If you have any queries or concerns regarding Codeine Phosphate 90 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider or pharmacist. They can provide you with comprehensive information about how this medication works and guide you on how to use it safely and effectively.
Codeine Phosphate 90 mg Slow Release Capsules is a compounded formulation of the opioid medication, codeine phosphate. It is designed to gradually release the active ingredient over an extended period of time for sustained therapeutic effects.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to gradually release the encapsulated medication over an extended period of time, offering sustained therapeutic effects, reduced dosing frequency, and improved patient compliance.
A slow release formulation offers several benefits. It provides sustained therapeutic effects over an extended period of time, reduces the frequency of dosing, and improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
The frequency of dosing will depend on your doctor's prescription. However, due to the slow release formulation, the frequency of dosing is typically reduced compared to regular formulations.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
No, you should not crush or chew the capsules. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
Side effects may include nausea, vomiting, constipation, lightheadedness, dizziness, or drowsiness. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Codeine Phosphate 90 mg Slow Release Capsules should only be used during pregnancy or breastfeeding if the potential benefits justify the potential risks to the baby. Always consult your healthcare provider before starting any new medication.
No, you should avoid alcohol while taking this medication as it can increase the risk of serious side effects such as severe drowsiness, dizziness, and difficulty breathing.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Symptoms of overdose may include slow breathing, slow heartbeat, coma.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
